Glaxosmithkline Share News (GSK)

GSK gets a lift as Express Scripts reinstates lung drug Advair

* Advair restored to Express Scripts 2015 formulary list * Move may boost use but prices still seen under pressure * GSK diabetes drug Tanzeum not included in Express list * GSK shares up 1.3 percent By Ben Hirschler LONDON, Aug 4 (Reuters) - GlaxoSmithKline (GSK) r

UK Dividends Calendar - Week Ahead

Private equity firms mull merger of older GSK, Sanofi brands -FT

Aug 3 (Reuters) - Private equity firms are mulling over a $10 billion plan to buy and merge older drug brands of Britain's GlaxoSmithKline and France's Sanofi, the Financial Times reported on Sunday, citing sources. U.S.-based KKR and Warburg Pincus were among the firms considering making b

MEDIA-Private equity firms consider merger of older GSK, Sanofi drug brands - FT

-- Source link: (http://on.ft.com/1oo8n5j) -- Note: Reuters has not verified this story and does not vouch for its accuracy

UK Dividends Calendar - Week Ahead

Pfizer bid for GSK "has some merits", says Berenberg

LONDON, Aug 1 (Reuters) - Could Pfizer acquire GlaxoSmithKline as a "plan B" after failing to land AstraZeneca? It would be a stretch but not totally impossible, according to analysts at Berenberg Bank. GSK's market capitalisation has slumped to $117 billion, or just under Pfizer's failed o

UK MIDDAY BRIEFING: Smith & Nephew Confident In Outlook

Glaxo, Genmab Phase III Ofatumumab Study Meets Primary Endpoint

UK Dividends Calendar - Week Ahead

U.S. FDA approves Boehringer Ingelheim lung disease drug

WASHINGTON, July 31 (Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Boehringer Ingelheim's drug to treat chronic obstructive pulmonary disease (COPD), an umbrella term that includes chronic bronchitis and emphysema. The drug, Striverdi Respimat, known also

UK Dividends Calendar - Week Ahead

UPDATE 3-AstraZeneca raises forecasts after seeing off Pfizer

* One-off payments and tax benefit flatter Q2 results * Investors focused on possible Pfizer return * Q2 revenue $6.45 billion vs consensus $6.29 billion * Q2 core EPS $1.30 vs consensus $1.10 * Now assuming generic Nexium in U.S. from Oct. 1 (Adds CEO comments from conf

UK Dividends Calendar - Week Ahead

Drug-resistant malaria reaches Southeast Asia borders, could spread to Africa

* Study finds drug resistance in critical Asian regions * Cambodia, Myanmar, Thailand among countries affected * Fears malarial drug resistance could spread to Africa * Mosquito-borne disease kills over 600,000 people a year By Kate Kelland LONDON, July 30 (Reuters)

UK Dividends Calendar - Week Ahead